Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

NCT03081910 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

T-cell Acute Lymphoblastic Lymphoma
T-non-Hodgkin Lymphoma
T-cell Acute Lymphoblastic Leukemia

Interventions

GENETIC: Autologous CD5.CAR/28zeta CAR T cells
GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]